Zydus Wellness Ltd
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
- Market Cap ₹ 18,864 Cr.
- Current Price ₹ 593
- High / Low ₹ 608 / 358
- Stock P/E 411
- Book Value ₹ 127
- Dividend Yield 0.20 %
- ROCE 1.69 %
- ROE 1.14 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 108%
Cons
- Stock is trading at 4.75 times its book value
- Company has a low return on equity of 0.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 219 | 200 | 225 | 264 | 255 | 153 | 114 | 216 | 251 | 245 | 354 | 582 | |
| 126 | 122 | 137 | 152 | 182 | 174 | 164 | 222 | 213 | 212 | 312 | 498 | |
| Operating Profit | 93 | 78 | 88 | 112 | 72 | -21 | -50 | -5 | 38 | 33 | 42 | 84 |
| OPM % | 42% | 39% | 39% | 42% | 28% | -14% | -44% | -2% | 15% | 13% | 12% | 14% |
| 20 | 30 | 25 | 28 | 57 | 109 | -60 | 15 | 13 | 18 | 12 | 1 | |
| Interest | 0 | 0 | 0 | 2 | 30 | 140 | 75 | 2 | 1 | 3 | 4 | 11 |
| Depreciation | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 10 | 25 |
| Profit before tax | 109 | 104 | 109 | 134 | 97 | -55 | -188 | 5 | 47 | 45 | 40 | 49 |
| Tax % | -0% | 1% | -1% | 0% | 1% | -26% | -3% | -143% | -41% | 25% | 25% | 23% |
| 109 | 103 | 109 | 134 | 96 | -41 | -182 | 13 | 66 | 34 | 30 | 38 | |
| EPS in Rs | 5.58 | 5.28 | 5.60 | 6.85 | 3.34 | -1.41 | -5.72 | 0.40 | 2.09 | 1.06 | 0.93 | 1.18 |
| Dividend Payout % | 22% | 25% | 23% | 23% | 30% | -71% | -17% | 251% | 48% | 94% | 128% | 101% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 39% |
| 3 Years: | 32% |
| TTM: | 64% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 23% |
| 3 Years: | -11% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 6% |
| 3 Years: | 27% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 | 64 |
| Reserves | 367 | 440 | 518 | 652 | 3,268 | 3,157 | 3,956 | 3,937 | 3,971 | 3,972 | 3,970 | 3,969 |
| 0 | 0 | 25 | 25 | 1,566 | 1,516 | 50 | 46 | 0 | 51 | 130 | 181 | |
| 45 | 19 | 23 | 23 | 62 | 72 | 47 | 44 | 32 | 29 | 88 | 60 | |
| Total Liabilities | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
| 44 | 43 | 40 | 38 | 37 | 43 | 44 | 45 | 54 | 54 | 432 | 420 | |
| CWIP | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 4 | 8 | 5 |
| Investments | 100 | 209 | 254 | 294 | 3,690 | 3,528 | 3,671 | 3,683 | 3,698 | 3,676 | 3,678 | 3,671 |
| 306 | 245 | 310 | 407 | 1,226 | 1,231 | 400 | 360 | 314 | 382 | 133 | 178 | |
| Total Assets | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89 | 79 | 88 | 113 | 86 | -20 | -52 | -16 | 37 | 26 | 40 | 35 | |
| 70 | -19 | -78 | -109 | -4,131 | 267 | 816 | 39 | 1 | -47 | -88 | -32 | |
| -27 | -58 | -6 | -2 | 4,049 | -260 | -710 | -38 | -79 | 15 | 43 | -0 | |
| Net Cash Flow | 131 | 1 | 4 | 2 | 4 | -13 | 54 | -15 | -42 | -6 | -5 | 3 |
| Free Cash Flow | 93 | 77 | 87 | 111 | 82 | -28 | -55 | -21 | 25 | 20 | 29 | 27 |
| CFO/OP | 98% | 103% | 100% | 99% | 123% | 96% | 109% | 255% | 96% | 80% | 90% | 44% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 0 | 1 | 1 | 9 | 1 | 5 | 19 | 4 | 12 | 25 | 17 |
| Inventory Days | 25 | 23 | 38 | 32 | 24 | 57 | 67 | 22 | 20 | 23 | 43 | 28 |
| Days Payable | 58 | 71 | 93 | 84 | 106 | 151 | 158 | 75 | 44 | 45 | 54 | 43 |
| Cash Conversion Cycle | -32 | -48 | -55 | -50 | -73 | -93 | -85 | -34 | -20 | -10 | 13 | 3 |
| Working Capital Days | -63 | -23 | -61 | -50 | -104 | -65 | -145 | -59 | 144 | 63 | -76 | 0 |
| ROCE % | 30% | 23% | 21% | 21% | 4% | 2% | 0% | 0% | 1% | 1% | 1% | 2% |
Insights
In beta| Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sugar Free Market Share (Sugar substitute category) % |
|
|||||||
| Complan Market Share (Nutrition drink / HFD category) % |
||||||||
| Everyuth Market Share (Facial cleansing overall category) % |
||||||||
| Glucon-D Market Share (Glucose powder category) % |
||||||||
| Nycil Market Share (Prickly heat powder category) % |
||||||||
| Organised Trade Saliency (% of domestic revenue) % |
||||||||
| Direct Distribution Reach (Company direct coverage in lakhs of outlets) lakhs of outlets |
||||||||
| Total Reach (Distribution - stores in millions, Nielsen reported) million stores |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30, 2026
17h - Board meeting on August 4, 2026 to consider Q1 FY27 unaudited financial results; trading window closes until August 6.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Jul - Newspaper publication regarding 32nd Annual General Meeting of the Company
-
Receipt Of Order From Tax Authority By Step Down Subsidiary
11 Jul - Polish tax authority fined subsidiary CCL PLN 54,000 for delayed Intrastat filings for Jan-Sep 2023.
-
BRSR For FY 2025-26
10 Jul - Submitted FY 2025-26 Business Responsibility and Sustainability Report.
-
Notice Of 32Nd AGM Scheduled On August 4, 2026
10 Jul - AGM on Aug 4, 2026; FY26 annual report issued, dividend record date July 17.
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
May 2026Transcript PPT REC
-
Mar 2026TranscriptAI SummaryPPT
-
Mar 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Jul 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Oct 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Jan 2021TranscriptPPT
-
Oct 2020TranscriptPPT
-
Sep 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptPPT
-
May 2020TranscriptPPT
-
Jan 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Oct 2018TranscriptPPT
-
Jul 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Jan 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Feb 2017TranscriptAI SummaryPPT
-
Nov 2016Transcript PPT
-
Jul 2016TranscriptPPT
-
Jun 2016TranscriptAI SummaryPPT
Business Segments:[1]
Zydus Wellness operates primarily in the consumer wellness sector. Its key segments include:
a)Food & Nutrition: Notable brands and products such as Glucon-D, Complan, and Sugar-Free.
b) Personal Care: This segment covers products like Everyuth, Scrubs Peel-off masks, and Nycil Prickly Heat Powder.